EMA publishes agenda for 25-28 February 2019 CHMP meeting

EMA

25 February 2019 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue initial opinions for the following technologies:

  • Zanamavir
  • Lorlatinib
  • Andexanet alfa
  • Pegvaliase
  • Paclitaxel
  • Rizankizumab
  • Volanesorsen
  • Sotigliflozin

Read CHMP agenda


Michael Wonder

Posted by:

Michael Wonder